Low LeverageVery low leverage materially reduces refinancing and solvency risk, giving management time and optionality to execute a strategic pivot. Over 2–6 months this buffer supports restructuring, M&A flexibility, or bridge financing without imminent default pressure.
Healthy Gross MarginA ~44% gross margin signals solid unit economics and pricing power at the product level, especially for private-label goods. If operating expense discipline continues, these margins can underpin sustainable profitability as volumes recover.
High Repeat Purchase & Strategic PivotA 69.7% repeat purchase rate indicates strong customer retention; combined with a strategic shift to private-label health products aligned with national policy, this can create durable LTV improvements and steadier revenue if product-market fit holds.